Evidence map›Paper›PMID 35800586›Full record

ArticleJournal of family medicine and primary care2022

Clinical characteristics of 200 COVID-19 patients in Mashhad, Iran, February and March 2020.

Mina AkbariRad, Abolghasem Allahyari, Sahar Ravanshad, Shima Nabavi Mahali, Farnoosh Ebrahimzadeh, Mahnaz Mozdourian, Zahra Javidarabshahi, Mohsen Seddigh-Shamsi, Maryam Emadzade, AmirAli Moodi Ghalibaf

Abstract read
In one paragraph

Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mina AkbariRadDepartment of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abolghasem AllahyariDepartment of Hematology Oncology, Mashhad University of Medical Sciences, Mashhad, Iran.
Sahar RavanshadDepartment of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Shima Nabavi MahaliDepartment of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Farnoosh EbrahimzadehDepartment of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahnaz MozdourianDepartment of Pulmonology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra JavidarabshahiDepartment of Pulmonology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohsen Seddigh-ShamsiDepartment of Hematology Oncology, Mashhad University of Medical Sciences, Mashhad, Iran.
Maryam EmadzadeDepartment of Clinical Research Development Unit, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
AmirAli Moodi GhalibafDepartment of Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is a pulmonary involvement which was reported for the first time in December 2019 in the city of Wuhan, Hubei province, China. The aim of the study was to describe the demographic, clinical, laboratory, and radiological characteristics of 204 definitive laboratory-confirmed COVID-19 patients hospitalized in Mashhad, Khorasan Razavi province, Iran. Patients and Methods: This study was performed on 204 laboratory-confirmed COVID-19 patients. A set of laboratory tests combined with various patient information and results from lung high-resolution computed tomography (HRCT) were gathered in a checklist and analyzed to give us a better view of patients who are hospitalized due to the complications caused by this disease. Results: The average age of our patients was 58.83 ± 15.93 years. There were 122 (59.8%) male and 82 (40.2%) female patients, and almost all of our patients had at least one underlying disease. Nine (4.4%) of our patients reported having gone for a trip to COVID-19-epidemic areas in the last 2 weeks. The most common signs shared among all our patients were cough, fever, and decreased O Conclusion: Based on our results, the most common signs of this disease are fever, cough, and shortness of breath, similar to seasonal influenza. Our data on disease severity showed that 33 (16.2%) patients had moderate disease, 139 (68.1%) had severe disease, and 28 (13.7%) were critical; 22 (10.8%) of our hospitalized patients died due to the complications of this disease.

Indexed as

CoronavirusCOVID-19SARS-COV-2

Identifiers

PMID35800586
PMCPMC9254816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.